|
|
Stabilization and ManufacturingOne of the goals of INCELL’s vaccines program is the stabilization of vaccines that are made of whole organisms, vaccine subunits, nucleic acids, and novel delivery, microencapsulation and nanotechnology. Focus is on non-needle delivery as described above. INCELL has a commitment to accelerating cost-effective product development and to “breaking the cold chain” for vaccines and other heat-labile products, new formulas, protectants and alternate packaging. INCELL is developing innovative approaches that will help break the cold chain for vaccine transport and delivery and thus reduce the product costs and increase the probability that the vaccine or therapy remains active and was not compromised in the transport process. This work is being done with an extensive collaborative network of companies, academic investigators and government agencies, including:
|
